secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immix Biopharma, Inc. (IMMX)
CIK:        0001873835
Form:       8-K
Filed at:   2023-03-22T23:59:59+00:00
Accession:  0001493152-23-008484
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immix Biopharma enters ATM facility to sell up to $5M in common stock
---------------------------------------------------------------------

- ATM Sales Agreement with ThinkEquity LLC for up to $5,000,000 of common stock.
- Shares sold at market prices; fixed commission of 3.75% of gross proceeds.
- Offering made under existing S-3 shelf registration statement declared effective Jan 2023.
- Expense deposit of $15,000 paid; legal fee reimbursement up to $50,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873835/000149315223008484/0001493152-23-008484-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873835/000149315223008484/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-008484

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer